MAPT and Alzheimer disease: Several preclinical studies have demonstrated that stress or increased CRF receptor 1 (CRFR1) signaling during stress contributes significantly to aberrant tau hyperphosphorylation and production of Aβ42, accelerating AD neuropathology (Kang et al., 2007; Dong et al., 2012).